Clemenstorgets Hjärtmottagning

Lund 222 21

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Risk, Chronic Kidney Disease, Inflammation, Obesity, Overweight, Type 2 Diabetes Mellitus

Studies at this site

• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — Completed
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed